Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The Manuscript Submission Check List, Title Page with Title and complete author details and Copyright Agreement Form have been completed and will be uploaded during submission.
  • The submission has not been previously published or is under consideration for publication in any other Journal (or an explanation has been provided in Comments to the Editor).

  • This submission will be the sole property of JSMC (Journal of Saidu Medical College)
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
  • It is hereby submitted that the manuscript has been seen and approved by all authors who have contributed significantly to satisfy the following authorship criteria and share in the responsibility for above. (*Kindly mention the role of individual author as per following criteria at the end of the article in a separate note).


    *AUTHORSHIP CRITERIA: All persons designated as authors should qualify for authorship. An “author” is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should:

    1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;

    2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and

    3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.

     

    All the check mark items, so far, constitute the Undertaking/Copyright Form for JSMC which can be downloaded under the heading of Author Guidelines, which is found in About the Journal. Please download this form, complete it and sign it and send us the Scanned copy of it with your submission. The file should be submitted as Supplementary file.


  • Please provide the names and e mail addresses of at least three subject specialists (by adding a word file as a supplementary file) who can possibly review the article.
  • I am attaching the Institutional Research Board (IRB) Approval for the submitted manuscript, as a Supplementary file.

Author Guidelines

PROCESSING/PUBLICATION FEE

Article processing fee Rs. 3000/- and must be deposited before sending the article for peer review and publication fee is Rs. 8,000/-.  Account No: CD 09592-00-5,  Bank of Khyber Mingora, Branch,  Code (0012),  A/C Name: Journal of Saidu Medical College, Saidu Sharif, Swat, Kindly deposit article processing and Publication Fee under intimation to this office by sending a deposit slip copy, by attachment through email/ postal service.

FUNDING SOURCES

The funding sources of  "Journal of Saidu Medical College" are;

1) Article processing and Publication fee submitted by the author.

2) Pharmaceutical industry advertisements.

ADVERTISEMENT POLICY

Advertisements are allowed only in printed version. Per page cost of each advertisement is Rs. 35000/-. The decision on advertismenet inclusioin or acceptance is the sole proragative of the Editorial Board. The advertisment applicant has no role in editorial decision making, selection of reserach articles for publication, rejection or acceptance of research article. They are never allowed to sit in editorial board meetings. 

 

WAIVER POLICY

JSMC offers a complete or partial fee waiver on a case-to-case basis for Undergraduate Medical students of Pakistan as well as authors from low-income countries (WHO-HINARI Group-A countries list)

EDITORIAL POLICY The "Journal of Saidu Medical College" is the official journal of Saidu Medical College, Swat, Pakistan. We are dedicated to encourage and facilitate research at all levels and in all fields of medicine. We are predominantly devoted to reporting original investigations in the biomedical and health sciences, including research in the basic sciences; clinical trials of therapeutic agents; effectiveness of diagnostic or therapeutic techniques; or studies relating to the behavioral, epidemiological or educational aspects of medicine. We consider articles on all topics pertaining to various disciplines of medicine for publication. Our goal is to provide the reader reports of original research conducted nationally and internationally, original clinical observations accompanied by analysis and discussion, analysis of philosophical, ethical, or social aspects of the health professions or biomedical sciences, critical reviews, case reports with discussions and feedback on articles in the form of letters to editors. The journal is intended primarily for those in the health professions: researchers, practitioners, educators, administrators, and students. The phrase health professionals includes physicians, nurses, dentists, veterinarians, and the many types of allied health professionals in the research and health care delivery systems. We especially encourage local research which has international application and contributes positively to the knowledge of diseases and problems not commonly encountered in the west.

MANUSCRIPTS SUBMISSION

The "Journal of Saidu Medical College" is a peer reviewed, quarterly published journal and follows the uniform requirements for Manuscripts submitted to Biomedical journals as approved by the International Committee of Medical Journal Editors as revised in 1997 published in N Eng J Med 1997; 336:309-15. The International Committee of Medical Journal Editors (ICMJE) has produced and updated the "Uniform Requirements for Manuscripts (URM) Submitted to Biomedical Journals". Detailed information can be downloaded from www.icmje.org.

All manuscripts should be accompanied by a covering letter from the author responsible for correspondence regarding the manuscript. The covering letter should contain the following copyright disclosure statement. We, the undersigned co-authors of this article, have contributed significantly to and share in the responsibility for above. The undersigned stipulate that the material submitted to Journal of Saidu Medical College, is new, original and has not been submitted to another publication for concurrent consideration. Upon acceptance by Journal of Saidu Medical College, all copyright ownership for the article is transferred to Journal of Saidu Medical College. It is attested that all human and/or animal studies undertaken as a part of the research are in compliance with regulation of our institution(s) and with generally accepted guidelines governing such work. It is attested that we have disclosed any and all financial or other relationships which could be construed as a conflict of interest and that all sources of financial support for this study have been disclosed and are indicated in the acknowledgment. This statement must be signed by all the major co authors. The covering letter should also contain statement that the manuscript has been seen and approved by all authors and should give any additional information which may be helpful to the Editor. If there has been any prior publication of any part of the work, this should be acknowledgement and appropriate written permission included. The journal is approved by Pakistan Medical & Dental Council and indexed with MEDLIP. It is available online on www.jsmc.pk and www.pakmedinet.com/jsmc.

UNDERTAKING / COPYRIGHT FORM: Download this form, complete it and sign it. Send us the Scanned copy of it with your submission. File should be submitted as Supplementary file.

FORMAT REQUIREMENTS 

While submitting manuscripts, please carefully follow the instructions given below: 

Summary of Technical Requirements 


1. The journal will accept: 
(a) Original research articles (b) Review articles (c) Special Articles (d) Short Comminication (e) Case reports (f) Case Series (g) Letter to the Editor and (h) Editorials. 
2. It should be typed in double space on one side of the A-4 size paper with clear margins on both sides. 
3. Begin each section or component on a new page. 
4. Review the sequence: title page, abstract and key words, text, acknowledgments, references, tables (each on separate page), legends.
5. Illustrations, un-mounted prints, should not be larger than 203 × 254 mm (8 × 10 inches). 
6. Include permission to reproduce previously published material or to use illustrations that may identify human subjects. 
7. Keep copies of everything submitted. 

All manuscripts of original research should contain following sections:
a) Title Page 
The title page should carry 
1) The title of the article, which should be concise but informative. 
2) Full name of each author, with his or her highest academic degree(s) and institutional affiliation.
3) The name of the department(s) and institution(s) to which the work should be attributed.
4) Disclaimers, if any. 
5) The name and address of the author responsible for correspondence about the manuscript. 
6) The name and address of the author to whom requests for reprints should be 
addressed source(s) of support in the form of grants, equipment, drugs, or all of these. 
7) A short running head or foot line of no more than 40 characters (count letters and spaces) at the foot of the title page. 
b) Abstract and Key Words 
The second page should carry structured abstract of not more than 250 words. 
The abstract should state the Background: Brief introducation of the subject Objective: purpose of the study or investigation, Materials and Methods: basic procedures as selection of study subjects or laboratory animals; observational and analytical methods; Results: main findings giving specific data and their statistical significance, Conclusion: and the principal conclusions. It should emphasize new and important aspects of the study or observations. Below the abstract authors should provide, and identify as such, 3 to 10 key words or short phrases that will assist indexers in cross-indexing the article and may be published with the abstract. Terms from the Medical Subject Headings (MeSH) list of Index Medicus should be used; if suitable MeSH terms are not yet available for recently introduced terms, present terms may be used. 

c) Introduction 
State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported. 
d) Materials and Methods
The selection of the observational or experimental subjects (patients or laboratory animals, including controls), age, sex, and other important characteristics of the subjects should be clearly desribed. The guiding principle should be clear about how and why a study was done in a particular way incusion and exclusion criteria should be mentioned. For example, authors should explain why only subjects of certain ages were included or why women were excluded. Authors should avoid terms such as "race," which lacks precise biological meaning, and use alternative descriptors such as "ethnicity" or "ethnic group" instead. Authors should specify carefully what the descriptors mean, and tell exactly how the data were collected (for example, what terms were used in survey forms, whether the data were self-reported or assigned by others, etc.). Reports of randomized clinical trials should present information on all major study elements, including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding). Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.

 Ethics 

When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed. The provision of Ethical Approval Report is a MUST, for all the Original Articles, after 1st January 2014.

Statistics 
Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as the use of P values, which fails to convey important quantitative information. Discuss the eligibility of experimental subjects. Give details about randomization. Describe the methods for and success of any blinding of observations. Report complications of treatment. Give numbers of observations. Report losses to observation (such as dropouts from a clinical trial). References for the design of the study and statistical methods should be to standard works when possible (with pages stated) rather than to papers in which the designs or methods were originally reported. Specify any general-use computer programs used. Put a general description of methods in the Methods section. When data are summarized in the Results section, specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Avoid nontechnical uses of technical terms in statistics, such as "random" (which implies a randomizing device), "normal," "significant," "correlations," and "sample." Define statistical terms, abbreviations, and most symbols. 
e) Results 
Present your results in logical sequence in the text, tables, and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. 
f) Discussion 
Emphasize the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material given in the Introduction or the Results section. Include in the Discussion section the implications of the findings and their limitations, including implications for future research. Relate the observations to other relevant studies. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not completely supported by the data. In particular, authors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly label them as such. Recommendations, when appropriate, may be included. 
g) Acknowledgments 
List all contributors who do not meet the criteria for authorship, such as a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Financial and material support should also be acknowledged. Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under a heading such as "clinical investigators" or "participating investigators," and their function or contribution should be described for example, "served as scientific advisors," "critically reviewed the study proposal," "collected data," or "provided and cared for study patients." Because readers may infer their endorsement of the data and conclusions, all persons must have given written permission to be acknowledged. 
h) References 
References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in text, tables, and legends by Arabic numerals in parentheses. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Consult the List of Journals Indexed in Index Medicus, published annually as a separate publication by the library and as a list in the January issue of Index Medicus. The list can also be obtained through the library's web site Avoid using abstracts as references. References to papers accepted but not yet published should be designated as "in press" or "forthcoming"; authors should obtain written permission to cite such papers as well as verification that they have been accepted for publication. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. For scientific articles, authors should obtain written permission and confirmation of accuracy from the source of a personal communication. The references must be verified by the author(s) against the original documents. The Uniform Requirements style (the Vancouver style) is based largely on an ANSI standard style adapted by the NLM for its databases. Notes have been added where Vancouver style differs from the style now used by NLM. 

i) Illustrations and legends 
Illustrations should be numbered in the order of their mention in the text and should be marked lightly on the back with the first author's last name and an arrow to indicate the top edge. Special charges will be made by the publisher for publishing figures in color. Before publication the corresponding author will be sent a cost estimate; at that time he or she may decide to pay the costs or print the illustration in black and white. Only good photographic prints of original drawings should be supplied. All lettering must be done professionally. Do not send original artwork, x-ray films, or ECG tracings. Glossy photographs are preferred; good black-and-white contrast is essential. Preferred size for submitted illustrations is 5 x 7 inches. Suitable figure legends should be typewritten double spaced on a separate sheet of paper and included at the end of the manuscript. If a figure has been taken from previously copyrighted material, the legend must give full credit to the original source and letters of permission must be submitted with the manuscript. Articles appear in both the print and online versions of the Journal, and wording of the letter should specify permission in all forms and media. Failure to get electronic permission rights may result in the images not appearing in the online version. Illustrations cannot be returned by the publisher. Figures should be submitted in electronic format. All images should be at least 5 inches wide. Graphics software such as Photoshop and Illustrator, not presentation software such as PowerPoint, CorelDraw, or Harvard Graphics, should be used in the creation of the art. Color images need to be CMYK, at least 300 DPI, and be accompanied by a digital color proof, not a color laser print or color photocopy. Please include hardware and software information, in addition to the file names.

j) Tables 
Tables should be self-explanatory and numbered in Roman numerals in the order of their mention in the text. Provide a brief title for each. Type each double-spaced on a separate page. Abbreviations should be defined in a double-spaced footnote at the end of the table. If any material in a table or a table itself has been taken from previously copyrighted material, a double spaced footnote must give full credit to the original source and permission of the author and publisher must be obtained. Send letters of permission to the Editor with the manuscript.
k) Short Reports 
Short Reports should be limited to three type written pages on current research, a short introduction, material and methods andresults should be written under the same heading followed by brief comments and six to ten reference.
l) Letters to the Editor 
Letters to the Editor are considered for publication (subject to editing and abridgment) provided they do not contain material that has been submitted or published elsewhere. The letter must be typewritten and double-spaced. Its text, not including reference, must not exceed 250 words if it is in reference to a recent journal article, or 400 words in all other cases (please provide a word count). It must have no more than five references and one figure or table. Letters referring to a recent journal article must be received within four weeks of its publication. Please include your full address, telephone number, fax number an e-mail address.

Commentary

Commentary

Special Communication

Special Communication

Acknowledgment

Acknowledgment

Privacy Statement

Journal of Saidu Medical College, Swat (JSMC) strongly believes in research integrity and follows the principles of transparency and best practice in scholarly publishing as suggested by leading organizations like  International Committee of Medical Journal Editors (ICMJE)World Association of Medical Editors (WAME), Committee of Publication Ethics (COPE), Council of Science Editors (CSE), Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA) and Pakistan Association of Medical Editors (PAME)

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

EDITORIAL ETHICAL POLICY

ANIMAL BASED STUDIES

Animal-based studies, or research articles conducted on animals, will not be considered for processing or publication in the JSMC effective immediately. Thus has been effective since 2015.

 

AUTHORSHIP

Journal of Saidu Medical College has agreed to receive and publish manuscripts in accordance with the instructions of International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE). Details of ICMJE and COPE are available at www.icmje.organd http://publicationethics.org/.

The ICMJE recommends that authorship should be based on the following four criteria:

  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  2. Drafting the work or revising it critically for important intellectual content; AND
  3. Final approval of the version to be published; AND
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All those designated as authors should meet all fourcriteria for authorship

ACKNOWLEDGMENT CRITERIA
Contributors who do not meet all the four criteria for authorship, but helped in the study, may be listed in the acknowledgement section. Examples of those who may be listed can include, but is not limited by, the following:

  • Individuals who helped in acquisition of funding
  • Individuals who generally supervised the research group
  • Individuals who provided general administrative support
  • Colleagues who helped in designing the study
  • Individuals who helped in reviewing the manuscript, including writing assistance, technical and language editing, and proofreading
  • Physicians who referred cases
  • Individuals who provided laboratory assistance
  • Statisticians for statistical tests and analysis
  • Secretarial help
  • Parents who responded to the questionnaire
  • Pharmaceutical companies
  • Organisations which may have helped
  • Concerned colleagues who provided micrographs, x-rays, or slides

 

ALTERATION IN THE LIST OF AUTHORS
JSMC does not prescribe to change in the authors list with respect to additions and deletions after the initial submission.

 

CONTRIBUTION STATEMENT 
Statements describing detailed contributions made by each author are required at the time of submission of the manuscript. This has to be outlined in the submission statement form. Incomplete form can lead to processing delays in the manuscript.

 

CORRESPONDING AUTHOR

The corresponding author is the individual who takes primary responsibility for communication with the journal. The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely way, and should be available after publication to respond to critiques of the work and cooperate with any requests from the journal for data or additional information should questions about the paper arise after publication.

 

DECEASED AUTHOR
Deceased authors should be included with a death dagger (†) next to the author's name, and a footnote stating that the author is deceased and giving the date of their death e.g. †Deceased 1 January 2016

 

CLINICAL TRIAL REGISTERATION

The publication of results of all randomized control trials will only be considered if the ICMJE recommendations are followed. A trial registration number will have to be provided with the manuscript and should be mentioned after the end of the abstract. The trial should have been registered prospectively. Retrospective registration will not be considered. If the Trial was conducted without registration, the article will not be accepted for processing.

The ICMJE defines a clinical trial as “any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioural treatments, educational programs, dietary interventions, quality improvement interventions, and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.”

The ICMJE endorses the following:

  1. Any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/network/primary/en/index.html)
  2. ClinicalTrials.gov

The Drug Regulatory Authority of Pakistan (DRAP) also provides approval and trial numbers for clinical trials involving drugs or appliances (http://www.dra.gov.pk/)

A number of other clinical trial registries and their details can be found on the internet.

Reference: http://www.icmje.org/icmje-recommendations.pdf

 

CONFLICT OF INTEREST

A sample definition by WAME states that conflict of interest “exists when a participant in the publication process (author, peer reviewer, or editor) has a competing interest that could unduly influence (or be reasonably seen to do so) his or her responsibilities in the publication process."

Any conflict of interest should be declared by all authors. This may include grants or honorarium, credits and promotions, memberships or any personal or professional relationships which may appear to influence the manuscript. Such competing interests are not unethical but should be declared.

Authors should state the conflict of interest clearly in the submission statement form. This statement should also appear at the end of the text before the references. If there are no conflicts of interests, the authors should state, “none to declare.”

JSMC will publish conflict-of-interest statement for each article

 

COPYRIGHT POLICY

When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the JSMC and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the JSMC.

Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to JSMC.

 

ETHICAL APPROVAL OF RESEARCH

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the latest version of Helsinki Declaration. Do not use patients' names, initials, or hospital numbers, in text and illustrative material.

When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Evidence should be provided that prior approval of the research project was obtained from the institutional committee responsible for animal care and use..

Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare (http://veteditors.org/ethicsconsensusguidelines.html).

Every manuscript submitted to JSMC should have the ethical approval by the ethical review board of the institution. The statement should be written on the official letterhead of the ERC or IRB duly stamped and signed by the Chairperson of the committee. The study should be approved prospectively. Studies not involving direct contacts with human subjects would require submission of an exemption letter issued by the institutional ERC/IRB before the starting date of the project.

If an institution does not have an ethical review committee, the approval should be sought from another institution adhering to ethical norms and govern research involving humans by means of Ethical Review Committees that are willing to cooperate in the enhancement of ethical standards.

All case reports require an approval on the institutional letterhead from the head of the department. A statement should be included that participants gave informed consent before being included in the study or for publication of a case report.

Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.

In case the manuscript is rejected, the copyright transfers back to the authors.

 

FUNDING DISCLOSURE

All sources of grants received and its spending should be disclosed. Such statements should be declared on the submission statement formand at the end of the manuscript before the references. If there are no funding sources, the authors should state “none to declare”.

 

PEER REVIEW POLICY

JSMC is a PEER REVIEWED journal following DOUBLE BLIND PEER REVIEW system. JSMC is having a panel of peer-reviewers with diversity in knowledge, viewpoint and expertise in relevant specialties.


Responsibilities of reviewers

  1. The first responsibility of reviewers is to evaluate manuscripts critically but constructively and to prepare detailed comments about the research and the manuscript to help authors improve their work. The reviewers have to assess the manuscript according to the reviewers’ proforma sent to each reviewer along with the manuscript. The evaluation should include:
  • Assessments of the originality and importance of the research;
    The design of the study;
    • The methods of study, including analytic and statistical methods;
    • The presentation of the results;
    • Important findings of results discussed with new emerging findings
    • Possible confounding; the strength of the conclusions
    • The overall quality of the manuscript.
  1. The second responsibility is to make recommendations to the editor regarding the suitability of the manuscript for publication in that journal. Reviewers may be asked to write some narrative comments about the manuscript that support their recommendation to the editor regarding acceptance or rejection. They also can be asked to grade some characteristics of the manuscript, such as originality, quality, accuracy, readability and interest to readers, or to complete detailed questionnaires about these qualities and even assign a priority score.
  2. Reviewers should declare to the editor any potential conflicts of interest with respect to the authors or the content of a manuscript they are asked to review, and in most instances when such conflicts exist should decline to review the manuscript.
  3. Other responsibilities of reviewers include treating the manuscript as a confidential document and completing the review promptly. Reviewers should not show the manuscript to anyone else without the express consent of the editor.
  4. Reviewers should not make derogatory comments about the manuscript in their comments for the authors. If reviewers do make such comments, the editor may choose to edit the comments or even withhold all the reviewer’s comments from the authors.
  5. Reviewers must not make any use of the work described in the manuscript.
  6. Reviewers should not communicate directly with authors or even identify themselves to authors, except by signing their reviews.
  7. The editor will provide guidance to the reviewers, particularly new reviewers, regarding how the editor wishes the reviewers to evaluate the manuscript and how the reviewers should meet their dual responsibility of providing constructive comments for the author and advice to the editor.
  8. Reviewers should meet the agreed-upon deadline (usually 4 weeks) for manuscript review and should respond to the reminders if sent any.

Identification and evaluation of reviewers

  1. The editor will establish a reviewer database that includes information about the expertise of each reviewer as well as addresses and other contact information.
  2. The editor may identify potential reviewers on the basis of personal knowledge of the topic or from among the authors of references in the manuscript, the membership of the professional societies, colleagues at affiliated institutions, or computer searches of databases such as PubMed, Medline, Publon etc or by asking for names from reviewers who decline to review the manuscript (see below).
  3. Only those reviewers who consent to be on review panel will be added to the JSMC online review and tracking system.
  4. Authors may suggest reviewers for their manuscript, whether invited to do so by the editor or not. The editor may choose to use one or more of these reviewers, but are under no obligation to do so. Authors may ask that certain people not be asked to review their manuscript and editor may decide the case accordingly.
  5. The editor should ask reviewers, by telephone, fax or e-mail, if they are willing to review a particular manuscript, and give them a date that the review is due at the editorial office (usually 3 to 4 weeks), rather than simply sending the manuscript to the reviewer. As the same time, the editor can ask for the names of others who might review the manuscript should the person initially contacted decline.
  6. The editor is responsible for keeping track of reviewers, and taking steps to make sure reviews are completed in a timely manner. Each peer review is rated by the editor assigned to the manuscript and stored with the reviewer’s profile in the Rapid Review reviewer database. This rating becomes part of the reviewing history of each peer reviewer, and can be viewed by the editors as they select potential reviewers for future manuscripts. The reviewer database also contains information on the reviewers’ areas of expertise; the number of previous invitations to review and number accepted; dates of submitted reviews, and days taken to produce reviews. Reviewers who consistently decline invitations or who write brief unhelpful reviews are eventually removed from the database.
  7. To avoid overworking reviewers, each reviewer will be asked to evaluate no more than one manuscript per month. Reviewer has the right to decline the review due to any reason.

 

Note: Due to blind peer review policy, review details are not shared publicly, however can be shared to International Indexing agencies, Higher Education commission Pakistan & Pakistan Medical & Dental Council on demand or during journal evaluation process, as the case may be.


Rewarding reviewers 

  • “Thank you” email will be sent immediately on completion of the review to each reviewer through online review system.
  • Review-credit certificate, duly signed by the editor will be sent through email to the reviewer on demand.
  • Names of reviewers will be published online as well as in print copy of the journal.
  • Reviewer may claim the credit of review, after getting registered as reviewer on


PUBLONS  

REVIEWER CREDIT 


DECISION MAKING AND COMMUNICATION TO AUTHORS

  • The editor makes a decision about the manuscript (accept, invite a revision, or reject) based on a consideration of all the reviewer comments, his own critique, and other external factors.
  • What considerations should enter into the decision? These may include the comments and recommendations of the reviewers, the availability of space, and the most important is the judgment of the editor(s) regarding the suitability of the manuscript for the journal and the value and interest of the manuscript to the journal readers.
  • The editor may always seek additional review and advice if required.
  • Editor will communicate the decisions to authors. This means that the editor may need to provide explanations for the decision independent of the comments of the reviewers that are to be sent to the authors.
  • Decisions to reject a manuscript may be based on scientific weakness (poor research design, inappropriate methods of study), lack of originality, lack of importance and interest to readers, or simply lack of space. The editor will explain to authors the reasons for decisions to reject manuscripts. This is particularly important when the editor rejects a manuscript but the tone of the comments of the reviewers that will be sent to the authors is favorable.
  • The editor should actively encourage revision of manuscripts thought to be potentially acceptable. When an editor seeks revision of a manuscript, he should make clear which revisions are essential, and which are optional.
  • If the comments of the reviewers are contradictory, the editor must decide and tell the authors which comments the authors should follow. Editors may add their own comments and suggestions for revision, and they (or some person in the editorial office designated by the editor) are responsible for ensuring that manuscripts meet the journal.

 

COMPLAINT POLICY

  • If any reader, author or reviewer has any complaints against the journal, its staff, editorial board or publisher, it may be submitted to "editorjsmc@gmail.com" through an email with a subject mentioning COMPLAINT.
  • Complaints may also be submitted regarding issues related to inappropriate authorship, gift and ghost authorship; undeclared conflicts of interests, plagiarism, multiple, duplicate, concurrent publication/simultaneous submission, unethical research; fabrication/falsification of results, selective reporting; research standards violations, reviewer bias/competitive harmful acts by reviewers or any contribution to JSMC that infringes copyright or other intellectual property rights.
  • JSMC will investigate the complaint and after enquiry report, JSMC will establish a decision about the complaint, which will be communicated to all relevant quarters.
  • Although every effort is taken to improve the standard of JSMC and to make it free from errors, however, we accept that occasionally mistakes might happen. JSMC welcomes highlighting any error or mistake to be corrected.

 

REJECTED ARTICLES-APPEALS

Authors whose articles have been rejected have the right to send a letter of appeal giving detailed explanations. This will be reviewed in-house and a decision will be taken accordingly.

Revised articles will not be considered at this stage.

 

REPRODUCTION OF PREVIOUSLY PUBLISHED ARTICLES-APPEALS

Reproducing material from other sources.

It is the author's responsibility to secure all permissions prior to submission of the manuscript. Any part of the article accessed from another source, should be accompanied by a signed letter of consent from the copyright holder, which may be the author, journal or the publisher.

Reproducing material published by JSMC.

No part of the Journal may be reproduced, stored in a retrieval system, or transmitted in any form or by any other means, electronic, mechanical photocopying, recording or otherwise, without prior permission, in writing, of the Journal of the Saidu Medical College. This includes material previously published by the requesting author.

 

RESPONSES TO PUBLISHED WORK

Comments on previously published articles in JSMC will be reviewed by the editor-in-chief and forwarded to the authors of the published manuscript for a reply. Appropriate time will be given for the response. Both will be published simultaneously in one of the forthcoming issues. In case the author of the published article does not reply, the comments will be published on their own.

This process will only be undertaken if the comments are appropriate.

Please submit comments to published work through http://jsmc.pk/index.php/jsmc, Please see the Guidelines to Authors for details regarding the submission.

 

SCIENTIFIC MISCONDUCT (e.g; Plagiarism, falsification, fabrication of data etc)

JSMC follows the guidelines provided by the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME), the International Committee of Medical Journal Editors (ICMJE) and the Higher Education Commission, Pakistan (HEC) for dealing with scientific misconduct.

The following examples and forms of misconduct have been taken from WAME, originally with minor modification from the ORI publication Analysis of Institutional Policies for Responding to Allegations of Scientific Misconduct:

  • Falsification of data: ranges from fabrication to deceptive selective reporting of findings and omission of conflicting data, or wilful suppression and/or distortion of data.
  • Plagiarism: The appropriation of the language, ideas, or thoughts of another without crediting their true source, and representation of them as one's own original work.
  • Improprieties of authorship: Improper assignment of credit, such as excluding others, misrepresentation of the same material as original in more than one publication, inclusion of individuals as authors who have not made a definite contribution to the work published; or submission of multi-authored publications without the concurrence of all authors.
  • Misappropriation of the ideas of others: an important aspect of scholarly activity is the exchange of ideas among colleagues. Scholars can acquire novel ideas from others during the process of reviewing grant applications and manuscripts. However, improper use of such information can constitute fraud. Wholesale appropriation of such material constitutes misconduct.
  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results.
  • Material failure to comply with legislative and regulatory requirements affecting research: Including but not limited to serious or substantial, repeated, wilful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials.
  • Inappropriate behaviour in relation to misconduct: this includes unfounded or knowingly false accusations of misconduct, failure to report known or suspected misconduct, withholding or destruction of information relevant to a claim of misconduct and retaliation against persons involved in the allegation or investigation.

JSMC also includes redundant publication and duplicate publication, lack of declaration of competing interests and of funding/sponsorship, and other failures of transparency to be forms of misconduct.

 

RESPONSES TO POSSIBLE MISCONDUCT
All allegations of scientific misconduct are taken very seriously at JSMC. We follow the guidelines prescribed by the previously mentioned organisations. The manuscript processing will be halted while the fact-finding investigation is being carried out.

[1] WAME. Recommendations on Publication Ethics Policies for Medical Journals [Internet]. 2015 [cited 28 December 2015]. Available from: http://www.wame.org/about/recommendations-on-publication-ethics-policie

 

SELF-ARCHIVING POLICY

The Journal of Saidu Medical College allows authors’ self-archiving of the manuscript. The accepted manuscripts and published manuscripts in any form can be posted to any website, repository, social media group, institutional repository, or share with anyone without any restriction. The information can be seen on Sherpa Romeo, https://v2.sherpa.ac.uk/id/publication/22916.  

 

SUPPLEMENTS

JSMC is willing to accept supplement publishing requests made by external organisations based on different topics, abstracts, or meetings.

The cost of publishing the supplement will be paid by the requesting body after discussion with the journal management.

It is vital to note that all the articles published represent the opinions of the authors and do not reflect official policy of the journal.

For more details regarding supplements, please get in touch with the Journal at editorwww.jsmc.pk.

 

WITHDRAWAL POLICY

According to JSMC's copyright policy, the copyright belongs to the Journal upon submission of the manuscript. Moreover, it is considered unethical to submit the same manuscript to more than one journal at the same time.

If the authors want to withdraw the manuscript during its processing, an email has to be sent notifying as to their intention, to the effect that the manuscript withdrawal form will be emailed for the signatures of all the authors. This needs to be completed, scanned and sent back. A final letter from the editorial office for withdrawal of the manuscript will then be dispatched. Electronic signatures will not be accepted.

Please note that without a formal letter of withdrawal, a manuscript is not considered withdrawn and use of such a manuscript elsewhere will be construed as an ethical misconduct.

First Version: 1st January 2016

Second Version: 17th March 2017

Third (Current) Version: 6th February 2019